Addison Advisors
REGN icon

Addison Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Addison Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.52K Hold
2
– – ﹤0.01% 630
2026
Q2 		$1.25K Sell
2
-10
-83% -$6.81K ﹤0.01% 606
2026
Q1 		$9.27K Sell
12
-1
-8% -$766 ﹤0.01% 665
2025
Q4 		$10K Buy
13
+2
+18% +$1.36K ﹤0.01% 628
2025
Q3 		$6.19K Buy
11
+4
+57% +$2.26K ﹤0.01% 683
2025
Q2 		$3.68K Sell
7
-9
-56% -$5.02K ﹤0.01% 726
2025
Q1 		$10.1K Sell
16
-8
-33% -$5.5K ﹤0.01% 580
2024
Q4 		$17.1K Buy
24
+10
+71% +$8.39K ﹤0.01% 521
2024
Q3 		$14.7K Sell
14
-2
-13% -$2.23K ﹤0.01% 547
2024
Q2 		$16.8K Sell
16
-5
-24% -$4.85K 0.01% 503
2024
Q1 		$20.2K Sell
21
-17
-45% -$16.2K 0.01% 459
2023
Q4 		$33.4K Hold
38
– – 0.01% 399
2023
Q3 		$31.3K Sell
38
-8
-17% -$6.29K 0.01% 374
2023
Q2 		$33.1K Hold
46
– – 0.02% 365
2023
Q1 		$37.8K Sell
46
-2
-4% -$1.51K 0.02% 330
2022
Q4 		$34.6K Hold
48
– – 0.02% 320
2022
Q3 		$33K Hold
48
– – 0.02% 301
2022
Q2 		$28K Hold
48
– – 0.02% 328
2022
Q1 		$34K Buy
48
+33
+220% +$20.9K 0.02% 337
2021
Q4 		$9K Buy
15
+13
+650% +$7.99K 0.01% 418
2021
Q3 		$1K Hold
2
– – ﹤0.01% 425
2021
Q2 		$1K Buy
+2
New +$1.01K ﹤0.01% 391

Other funds holding REGN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Addison Advisors's REGN Position: Q3 2026 in Review

Addison Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 2 shares worth $1.52K. The position accounts for ﹤0.01% of the portfolio, ranked #630.

Addison Advisors first reported a position in REGN in Q2 2021 and has held it in 22 quarters since. The position peaked at $37.8K in Q1 2023. 817 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Addison Advisors held 2 shares of Regeneron Pharmaceuticals worth $1.52K as of Q3 2026.
  • Addison Advisors left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Addison Advisors's portfolio in Q3 2026, its #630 holding.
  • Addison Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 22 quarters since.
  • Addison Advisors's Regeneron Pharmaceuticals position peaked at $37.8K in Q1 2023.
  • 817 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Addison Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.